Analysis of the LED Lamp Arrangement for Uniformity of Illumination in Indoor VLC System

Hao Hong-gang,Zhang Dan-dan,Tang Shuai 한국광학회 2014 Current Optics and Photonics Vol.18 No.6

LED lamp arrangement is a critical issue in indoor visible light communication (VLC) system. In this paper, we analyze the illumination distribution under the arrangement of 2×3 and propose a method to find the optimal lamp arrangement. The method, based on the MIMO (Multiple Input/Multiple Output) system model and taking the first order reflection into consideration, enables accurate analysis of the arrangement of the LED lamps for any room. The studies show that under the optimal arrangement the uniformity of illumination is improved from 0.55 to 0.86, which guarantees that users can get almost equal lighting effects, no matter where they locate themselves. At the same time, the RMS delay spread distribution which is used to evaluate the inter-signal-interference (ISI) is analyzed, and the simulation results indicate that the optimal arrangement also can improve the communication quality by reducing the fluctuation of the RMS delay spread.

Encapsulation, Pharmacokinetics and Tissue Distribution of Interferon α-2b Liposomes after Intramuscular Injection to Rats

Hao Li,Li Yang,Gang Cheng,Hong-Yan Wei,Qun Zeng 대한약학회 2011 Archives of Pharmacal Research Vol.34 No.6

The aim of the present study was to investigate the effect of liposome-encapsulation and liposome-size on the in vivo pharmacokinetics of interferon α-2b (IFNα-2b) following i.m. administration to rats, and whether there was any liver-targeting of these liposomes. Since liposomes of different sizes can be obtained by homogenization, the effect of homogenization on the IFNα-2b activity was also investigated. The pharmacokinetics of IFNα-2b solution (12.8 μg/kg) and IFNα-2b prepared in liposomes, including three mean sizes of 172 nm (12.2 μg/kg), 113 nm (44.2, 11.0, and 2.8 μg/kg, respectively), and 82 nm (13.1 μg/kg), were studied after a single i.m. dose to rats. Compared to a solution of IFNα-2b. administration of liposomal IFNα-2b resulted in a significantly prolonged t_max, the apparent elimination half life (t_(1/2β)) was 2.3 times longer, both AUC_(0-∞) and MRT_(0-∞) were also clearly enhanced and greater accumulation was obtained in the liver (p < 0.05). The AUC_(0-∞) increased proportionally to the administered dose of IFNα-2b liposomes. Moreover, the size of liposomes ranging from 82 nm to 172 nm had no significant difference on the pharmacokinetic behavior in vivo (p > 0.05). In sum, compared with the free form, IFNα-2b encapsulated in liposomes can alter strikingly the pharmacokinetics properties following i.m. injection and if a liposomal size ranging from 82 nm to 172 nm was used, consistent pharmacokinetic behaviors of IFNα-2b was exhibited. The liposomal formulation apparently targeted the liver, offering a potential advantage for hepatitis B treatment.

The optimization for the straight-channel PCHE size for supercritical CO₂ Brayton cycle

Xu, Hong,Duan, Chengjie,Ding, Hao,Li, Wenhuai,Zhang, Yaoli,Hong, Gang,Gong, Houjun Korean Nuclear Society 2021 Nuclear Engineering and Technology Vol.53 No.6

Printed Circuit Heat Exchanger (PCHE) is a widely used heat exchanger in the supercritical carbon dioxide (sCO₂) Brayton cycle because it can work under high temperature and pressure, and has been a hot topic in Next Generation Nuclear Plant (NGNP) projects for use as recuperators and condensers. Most previous studies focused on channel structures or shapes. However, no clear advancement has so far been seen in the allover size of the PCHE. In this paper, we proposed an optimal size of the PCHE with a fixed volume. Two boundary conditions of PCHE were simulated, respectively. When the volume of PCHE was fixed, the heat transfer rate and pressure loss were picked as the optimization objectives. The Pareto front was obtained by the Multi-objective optimization procedure. We got the optimized number of PCHE channels under two different boundary conditions from the Pareto front. The comprehensive performance can be increased by 5.3% while holding in the same volume. The numerical results from this study can be used to improve the design of PCHE with straight channels.

FBW7 Upregulation Enhances Cisplatin Cytotoxicity in Non-small Cell Lung Cancer Cells

Yu, Hao-Gang,Wei, Wei,Xia, Li-Hong,Han, Wei-Li,Zhao, Peng,Wu, Sheng-Jun,Li, Wei-Dong,Chen, Wei Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.11

Introduction: Lung cancer is extremely harmful to human health and has one of the highest worldwide incidences of all malignant tumors. Approximately 80% of lung cancers are classified as non-small cell lung cancers (NSCLCs). Cisplatin-based multidrug chemotherapy regimen is standard for such lesions, but drug resistance is an increasing problem. F-box/WD repeat-containing protein 7 (FBW7) is a member of the F-box protein family that regulates cell cycle progression, and cell growth and differentiation. FBW7 also functions as a tumor suppressor. Methods: We used cell viability assays, Western blotting, and immunofluorescence combined with siRNA interference or plasmid transfection to investigate the underlying mechanism of cisplatin resistance in NSCLC cells. Results: We found that FBW7 upregulation significantly increased cisplatin chemosensitivity and that cells expressing low levels of FBW7, such as NCI-H1299 cells, have a mesenchymal phenotype. Furthermore, siRNA-mediated silencing or plasmid-mediated upregulation of FBW7 resulted in altered epithelial-mesenchymal transition (EMT) patterns in NSCLC cells. These data support a role for FBW7 in regulating the EMT in NSCLC cells. Conclusion: FBW7 is a potential drug target for combating drug resistance and regulating the EMT in NSCLC cells.

Expression of Fatty Acid Synthase Negatively Correlates with PTEN and Predicts Peritoneal Dissemination of Human Gastric Cancer

Xiang, Hong-Gang,Hao, Jun,Zhang, Wen-Jie,Lu, Wen-Jie,Dong, Ping,Liu, Ying-Bin,Chen, Lei Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.16

Background: This study aimed to examine the clinical significance of fatty acid synthase (FASN) expression in gastric cancer (GC), and investigate any prognostic role. Materials and Methods: FASN expression was assessed in gastric cancers by immunohistochemistry using 60 paraffin-embedded tissue specimens, and clinical data were collected by retrospective chart review. Moreover, FASN mRNA expression in 15 fresh resected specimens was evaluated by the reverse transcription-polymerase chain reaction (RT-PCR). Immunohistochemical staining of PTEN was performed to assess the correlation of PTEN with FASN in gastric cancer. Results: Increased expression of FASN was noted in gastric cancers. The frequency of FASN gene amplification was also significantly higher in gastric cancer than in adjacent normal tissue. FASN expression in human gastric cancer tissues was significantly correlated with patient TNM stage and peritoneal dissemination (p<0.05). Moreover, higher FASN expression significantly correlated with shorter overall survival (p<0.05). Here, upregulation of FASN negatively correlated with PTEN expression in gastric cancer. Conclusions: These findings indicate that FASN expression is upregulated in gastric cancer, and increased FASN may be critical to th peritoneal metastasis and survival. Our results suggest that FASN upregulation and PTEN downregualtion may be involved in peritoneal dissemination for gastric cancer progression.

A dynamic asymmetrical crack model of bridging fiber pull-out in unidirectional composite materials

Xin-gang Li,Yun-hong Cheng,Nian-chun Lü,Guo-dong Hao,Jin Cheng 대한기계학회 2011 JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY Vol.25 No.9

As a rule, when a crack happens in composite materials, the fibrous system will generate bridging fibers resulted in the asymmetrical extending of the crack. In this paper, a dynamic asymmetrical crack model of bridging fiber pull-out in unidirectional composite materials is built for analyzing the distributions stress and displacement with the internal asymmetrical crack under the loading conditions of an applied non- stress and the traction forces on crack faces yielded by the bridging fiber pull-out model. Thus the fiber failure is determined by the maximum tensile stress, the fiber ruptures, and hence the crack propagation should also occur in self-similar modality. The formulation involves the development of a Riemann-Hilbert problem. The analytical solution of an asymmetrical extension crack in unidirectional composite materials under the conditions of moving increasing loads Pt²/x² and Px²/t is concluded, respectively. Based on relative material properties, the variable law of dynamic stress intensity factors was depicted perfectly. After the conclusion of analytical solutions with the superposition theorem, the solutions of arbitrary complex problems could be acquired.

Helicobacter pylori Chaperone-Like Protein CagT Plays an Essential Role in the Translocation of CagA into Host Cells

( Ding Hong Lei ),( Hao Zeng ),( Lin Ping Huang ),( Yan Dong Dong ),( Yi Jun Duan ),( Xu Hu Mao ),( Gang Guo ),( Quan Ming Zou ) 한국미생물 · 생명공학회 2012 Journal of microbiology and biotechnology Vol.22 No.10

Most of the Helicobacter pylori strains containing the cag pathogenicity island (PAI) have been associated with more severe gastric disease in infected humans. The cag PAI is composed of 27 proteins, and some of the components are required for CagA translocation into host cells as well as induction of proinflammatory cytokines, such as interleukin-8 (IL-8); however, the exact function of most of the components remains unknown or poorly characterized. In this study, we demonstrated that CagT (HP0532), which is an essential structural component of the cag PAI apparatus, plays an important role in the translocation of CagA into host epithelial cells. In addition to being located on the bacterial surface, CagT is also partially localized in the inner membrane, where it acts as a chaperone-like protein and promotes CagA translocation. However, CagT secretion was not detected by immunoprecipitation analysis of cell culture supernatants. Meanwhile, CagT was related to the introduction of IL-8 of the host cell. These results suggest that CagT is expressed on both the inner and outer bacterial membranes, where it serves as a unique type IV secretion system component that is involved in CagA secretion and cag PAI apparatus assembly.

Two new sesquiterpenoids from endophytic fungus J3 isolated from Mangrove Plant Ceriops tagal

Yan-Bo Zeng,Hai-Gang Gu,Wen-Jian Zuo,Li-Li Zhang,Hong-Jin Bai,Zhi-Kai Guo,Peter Proksch,Wen Li Mei,Hao Fu Dai 대한약학회 2015 Archives of Pharmacal Research Vol.38 No.5

Two new sesquiterpenoids, named 2a-hydroxyxylaranolB (1) and 4b-hydroxyxylaranol B (2), togetherwith a known diterpenoid 3,4-seco-sonderianol (3) wereisolated from the fermentation of endophytic fungus J3 ofCeriops tagal. Their structures were elucidated based onspectroscopic methods including 1D and 2D NMR(HMQC, 1H-1H COSY and HMBC). All compounds wereevaluated for their cytotoxic activities by MTT method,and compound 3 exhibited cytotoxic activities againstK562, SGC-7901, and BEL-7402 cell lines.

Expression of Ki67 in Papillary Thyroid Microcarcinoma and its Clinical Significance

Zhou, Yuan,Jiang, Hong-Gang,Lu, Ning,Lu, Bo-Hao,Chen, Zhi-Heng Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.4

Purpose: To investigate the expression of Ki67 protein in papillary thyroid microcarcinoma(PTMC), and to analyze its clinical significance. Materials and Methods: Ki67 protein expression was evaluated in the tissues of 108 human PTMC and 50 other benign papillary hyperplasia of thyroid specimens using immunohistochemistry. Results: The expression intensity of Ki67 in PTMC and benign papillary hyperplasia of thyroid specimens were $1.45{\pm}1.83%$ and $0.46{\pm}0.46%$.The positive expression rates were 46.3% and 14%. There were significant differences between these two groups (p<0.01). There was no significant variation of the expression intensity and positive expression rates of Ki67 in PTMC with gender, age, position of the tumor and the level of TSH pre-operation (p>0.05), but these parameters varied with tumor size, invasion by membrane and cervical lymph node metastasis (p<0.05 or p<0.01). Conclusions: The expression of Ki67 in PTMC was related to tumor size, invasion by membrane and cervical lymph node metastasis, and could be the important indicator for judging clinical progress and estimating prognosis.

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell Histiocytosis

Ying Yang,Dong Wang,Lei Cui,Hong-Hao Ma,Li Zhang,Hong-Yun Lian,Qing Zhang,Xiao-Xi Zhao,Li-Ping Zhang,Yun-Ze Zhao,Na Li,Tian-You Wang,Zhi-Gang Li,Rui Zhang 대한암학회 2021 Cancer Research and Treatment Vol.53 No.1

Purpose We sought to investigate the effectiveness and safety of dabrafenib in children with BRAFV600E-mutated Langerhans cell histiocytosis (LCH). Materials and Methods A retrospective analysis was performed on 20 children with BRAFV600E-mutated LCH who were treated with dabrafenib. Results The median age at which the patients started taking dabrafenib was 2.3 years old (range, 0.6 to 6.5 years). The ratio of boys to girls was 2.3:1. The median follow-up time was 30.8 months (range, 18.9 to 43.6 months). There were 14 patients (70%) in the risk organ (RO)+ group and six patients (30%) in the RO– group. All patients were initially treated with traditional chemotherapy and then shifted to targeted therapy due to poor control of LCH or intolerance to chemotherapy. The overall objective response rate and the overall disease control rate were 65% and 75%, respectively. During treatment, circulating levels of cell-free BRAFV600E (cfBRAFV600E) became negative in 60% of the patients within a median period of 3.0 months (range, 1.0 to 9.0 months). Grade 2 or 3 adverse effects occurred in five patients. Conclusion Some children with BRAFV600E-mutated LCH may benefit from monotherapy with dabrafenib, especially high-risk patients with concomitant hemophagocytic lymphohistiocytosis and intolerance to chemotherapy. The safety of dabrafenib is notable. A prospective study with a larger sample size is required to determine the optimal dosage and treatment duration.